Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,457 | 11,357 | 9,085 | 11,831 | 14,534 |
| TOTAL | $9,328 | $12,035 | $9,404 | $12,446 | $15,377 |
| Non-Current Assets | |||||
| PPE Net | 142 | 157 | 167 | 183 | 198 |
| Other Non-Current Assets | 69 | 104 | 136 | 185 | 216 |
| TOTAL | $211 | $261 | $303 | $368 | $414 |
| Total Assets | $9,539 | $12,296 | $9,707 | $12,814 | $15,791 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 173 | 641 | 902 | 779 | 543 |
| Accrued Expenses | 2,083 | 1,647 | 1,356 | 1,025 | 1,519 |
| TOTAL | $2,326 | $2,392 | $2,396 | $1,939 | $2,194 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 37 | 70 |
| TOTAL | $N/A | $N/A | $N/A | $37 | $70 |
| Total Liabilities | $2,326 | $2,392 | $2,396 | $1,976 | $2,264 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 271 | 247 | 167 | 128 | 126 |
| Common Shares | N/A | N/A | N/A | N/A | 1 |
| Retained earnings | -137,311 | -134,531 | -131,982 | -128,380 | -125,649 |
| TOTAL | $7,213 | $9,904 | $7,311 | $10,838 | $13,527 |
| Total Liabilities And Equity | $9,539 | $12,296 | $9,707 | $12,814 | $15,791 |